Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
31 March, 2026
TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes
LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data
26 March, 2026
TROG welcomes new Board members and President-Elect
LATEST NEWS: 26 March 2026 We are delighted to